PMID: 15250234Jul 15, 2004Paper

Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia

Respiratory Medicine
Edyta MajewskaDariusz Nowak

Abstract

Bacterial pneumonia involves influx of activated phagocytes into distal airways. These cells release oxidants including H2O2, that may be exhaled or induce peroxidative damage to lung tissues with formation of thiobarbituric reactive substances (TBARs). To determine whether concentrations of H2O2 and TBARs in exhaled breath condensate (EBC) is elevated and correlate with systemic response to pneumonia during 10 days of hospital treatment. The concentration of H2O2 and TBARs was measured in EBC of 43 inpatients with community acquired pneumonia (CAP) and 20 healthy never smoked subjects over 10 days and were accompanied by monitoring of WBC count, serum concentration of C-reactive protein (CRP) and peroxyl radical-trapping capacity. Patients with CAP exhaled 4.6-, 3.7-, 3.9-, 3.3-times more H2O2 than healthy controls at 1st, 3rd, 5th and 10th day of treatment (P<0.05), respectively. EBC concentrations of TBARs were elevated at 1st and 3rd day. H2O2 and TBARs levels decreased along with treatment course. Correlation (P<0.05) was found between H2O2 levels and CRP and WBC count (r = 0.31) at 1st day and between TBARs and CRP at 5th (r = 0.34) and 10th day (r = 0.46). The mean H2O2 exhalation estimated over ten days of treatment cor...Continue Reading

References

Jan 1, 1992·Free Radical Research Communications·R SchreckP A Baeuerle
Sep 1, 1990·The Journal of Clinical Investigation·A M CantinR G Crystal
May 1, 1994·American Journal of Respiratory Cell and Molecular Biology·G DentH Magnussen
Oct 1, 1993·The American Review of Respiratory Disease·A W DohlmanJ A Royall
Sep 1, 1996·American Journal of Respiratory and Critical Care Medicine·P N DekhuijzenA Bast
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·J E RepineI Lankhorst
Nov 18, 1998·Biochemistry and Molecular Biology International·G BartoszM Bartosz
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·M Hensel, W J Kox
Dec 8, 2000·FEBS Letters·B HalliwellL H Long
Feb 13, 2001·Free Radical Biology & Medicine·D NowakM Król

❮ Previous
Next ❯

Citations

May 16, 2008·Environmental Health : a Global Access Science Source·Michael J EptonLeslie Brown
Apr 11, 2009·Antioxidants & Redox Signaling·Horst Fischer
Apr 17, 2008·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Henri KnoblochPetra Reinhold
Sep 2, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Robert StolarekDariusz Nowak
Aug 3, 2010·Infectious Disease Clinics of North America·David R MurdochTrevor P Anderson
Apr 29, 2008·Clinics in Chest Medicine·Robert L OwensDean R Hess
Sep 11, 2008·Pediatric Pulmonology·Silvia CarraroEugenio Baraldi
Apr 17, 2013·British Journal of Pharmacology·J D ChandlerB J Day
Mar 26, 2013·Respirology : Official Journal of the Asian Pacific Society of Respirology·Geoffrey WarwickDeborah H Yates
May 12, 2006·Redox Report : Communications in Free Radical Research·Wendy M BrooksMichael J Epton
Jul 17, 2012·Respiratory Medicine·Jacek KordiakDariusz Nowak
Mar 15, 2006·Respiratory Medicine·Erik-Jan D OudijkLeo Koenderman
Jan 3, 2015·Journal of Pharmaceutical and Biomedical Analysis·Vera MuccilliSalvatore Foti
Apr 21, 2019·Angewandte Chemie·Sarah H KlassMatthew B Francis
Oct 2, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Haishan Xu, Shijian Chu
Nov 10, 2013·Beilstein Journal of Nanotechnology·Maria A KomkovaOleg G Voronin
Sep 15, 2020·Advanced Materials·Meng QinYunfeng Lu
Aug 4, 2019·Nature Communications·Saskia F Erttmann, Nelson O Gekara
Jun 30, 2019·Oxidative Medicine and Cellular Longevity·Svetlana SoodaevaIldar Batyrshin
Apr 10, 2021·Frontiers in Cellular and Infection Microbiology·Yamil Sanchez-Rosario, Michael D L Johnson
Dec 11, 2021·Frontiers in Bioengineering and Biotechnology·Feifei LiYunfeng Lu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Respiration; International Review of Thoracic Diseases
W J C van BeurdenF W J M Smeenk
American Journal of Respiratory and Critical Care Medicine
I HorváthP J Barnes
American Journal of Respiratory and Critical Care Medicine
Konstantinos KostikasStelios Loukides
© 2022 Meta ULC. All rights reserved